Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBIO | AZN | AMGN | GILD | VRTX |
| Company | Crescent Biopharma Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 13.11 | 90.69 | 340.36 | 122.29 | 457.78 |
| High | 13.25 | 91.18 | 340.88 | 122.53 | 462.00 |
| Low | 12.30 | 90.22 | 330.79 | 120.38 | 455.49 |
| Latest | 12.55 | 90.37 | 330.69 | 120.66 | 456.20 |
| Change | -0.44 | +0.34 | -9.47 | -1.96 | -1.16 |
| % Change | -3.39% | +0.38% | -2.78% | -1.60% | -0.25% |
| Volume | 113,500 | 2,511,458 | 759,615 | 1,395,867 | 243,183 |
| 20-Day Average Volume | 175,454 | 5,285,635 | 2,770,826 | 6,688,005 | 1,379,302 |
| Previous Close | 12.99 | 90.03 | 340.16 | 122.62 | 457.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.41 | 89.84 | 337.58 | 124.32 | 433.03 |
| 20-Day Raw Stochastic | 4.69% | 61.97% | 54.69% | 30.60% | 86.96% |
| 20-Day Relative Strength | 45.14 | 59.48 | 55.67 | 47.25 | 63.55 |
| Weighted Alpha | -56.15 | +37.06 | +24.51 | +28.27 | +3.20 |
| Today's Opinion | 64% Sell | 100% Buy | 88% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 32% Sell | 100% Buy | 100% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 80% Sell | 64% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.01% since 11/28/25 | -2.62% since 11/28/25 | -3.98% since 11/28/25 | -4.11% since 11/28/25 | +5.25% since 11/28/25 |
| Low | 12.30 on 12/05/25 | 89.77 on 12/04/25 | 331.28 on 12/05/25 | 120.38 on 12/05/25 | 423.45 on 12/01/25 |
| High | 16.35 on 12/04/25 | 92.98 on 12/01/25 | 346.38 on 12/03/25 | 126.23 on 12/01/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +0.48% since 11/05/25 | +11.26% since 11/05/25 | +3.70% since 11/05/25 | -1.56% since 11/05/25 | +9.45% since 11/05/25 |
| Low | 12.30 on 12/05/25 | 83.37 on 11/06/25 | 312.52 on 11/06/25 | 117.13 on 11/10/25 | 406.67 on 11/07/25 |
| High | 16.35 on 12/04/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -12.29% since 09/05/25 | +10.51% since 09/05/25 | +16.95% since 09/05/25 | +4.88% since 09/05/25 | +15.22% since 09/05/25 |
| Low | 9.81 on 10/14/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 16.35 on 12/04/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -37.11% since 06/05/25 | +24.80% since 06/05/25 | +15.54% since 06/05/25 | +9.24% since 06/05/25 | +2.83% since 06/05/25 |
| Low | 9.81 on 10/14/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 21.40 on 06/25/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 180,470 | 279,221,376 | 183,169,696 | 152,132,192 | 116,040,920 |
| Shares Outstanding, K | 13,893 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 794,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -37,880,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -24,610,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.32 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.27 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/12/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | 08/20/15 | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.88 | 15.79 | 15.26 | 30.25 |